Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it will report ...

Valneva says European Commission plans to terminate supply deal Commission says no final decision has been made Britain has already cancelled vaccine contract May 16 (Reuters) - Valneva (VLS.PA), ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced its senior management ...

Add Yahoo as a preferred source to see more of our stories on Google. A Valneva scientist works in a laboratory. (Courtesy of https://valneva.com/media-kit/) This ...

European safety committee advises product information update after review of a safety signal for aseptic meningitis following Ixchiq vaccination against chikungunya.

The finish line is in sight for Valneva’s chikungunya virus (CHIKV) vaccine candidate. With antibody levels holding steady out to six months in the phase 3 clinical trial, Valneva is set to start the ...

PARIS, Sept 26 (Reuters) - French drugmaker Valneva (VLS.PA), opens new tab said on Monday it is in talks with a potential partner on producing an updated version of its COVID-19 vaccine that targets ...

Britain approved on Thursday Valneva's Covid-19 vaccine, making it the first country to give a nod to the French firm's coronavirus shot that is easier to store and involves a process widely used in ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Valneva SE (“Valneva” or “the ...

If you are wondering whether Valneva is priced attractively right now, it helps to step back and look at what the recent share performance and valuation metrics are really telling you. The stock last ...

(Reuters) -Valneva lost nearly a fifth of its value on Monday after the French drugmaker said its COVID-19 vaccine agreement with the European Commission was likely to be scrapped and it might have to ...